# A Study for Adolescents With Fibromyalgia Syndrome

> **NCT01089621** · PHASE4 · WITHDRAWN · sponsor: **Eli Lilly and Company**

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Duloxetine

## Key facts

- **NCT ID:** NCT01089621
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-03
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Terminated due to study design changes; zero patients enrolled.
- **Last updated:** 2019-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01089621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01089621, "A Study for Adolescents With Fibromyalgia Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01089621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*